Login / Signup
Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System.
Kazumasa Kotake
Satoru Mitsuboshi
Tomonari Hosokawa
Naoya Kitamura
Yasuhiro Kawakami
Published in:
Schizophrenia research (2023)
Keyphrases
</>
end stage renal disease
drug administration
ejection fraction
newly diagnosed
chronic kidney disease
acute kidney injury
peritoneal dialysis
prognostic factors